Familial breast cancer: Is it time to move from a reactive to a proactive role?

H. Harris; I. Nippert; C. Julian-Reynier; J. Schmidtke; C. Van Asperen; D. Gadzicki; A. Tibben; D. G. Evans

doi:10.1007/s10689-011-9434-1

Familial breast cancer: Is it time to move from a reactive to a proactive role?

H. Harris
, I. Nippert
, C. Julian-Reynier
, J. Schmidtke
, C. Van Asperen
, D. Gadzicki
, A. Tibben
, D. G. Evans^*

^*Corresponding author for this work

Division of Evolution, Infection and Genomics

UMIST
Westfalische Wilhelms-Universitat Munster
UMR 6242 CNRS
Medizinische Hochschule Hannover (Hannover Medical School)
Leiden University Medical Center
Sophia Children's Hospital
University Hospital of South Manchester NHS Foundation Trust

Research output: Contribution to journal › Article › peer-review

Abstract

In 2004 the NICE guidelines on familial breast cancer advised Health Care Professionals that they should not actively seek to identify women with a family history of breast cancer. We have carried out a review of the evidence base and a large scale questionnaire survey of health professionals in four European countries. There is overwhelming support amongst GPs and surgeons against the premise that that health care professionals should not be proactive in identifying patients at risk of familial breast cancer. This that suggest the time is right to overturn the NICE decision.

Original language	English
Pages (from-to)	501-503
Number of pages	3
Journal	Familial Cancer
Volume	10
Issue number	3
DOIs	https://doi.org/10.1007/s10689-011-9434-1
Publication status	Published - 1 Sept 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

BRCA1
BRCA2
Breast cancer
Mortality
Proactive
Screening

Access to Document

10.1007/s10689-011-9434-1

Cite this

@article{f383cb6853364d11b0c722417f203a89,

title = "Familial breast cancer: Is it time to move from a reactive to a proactive role?",

abstract = "In 2004 the NICE guidelines on familial breast cancer advised Health Care Professionals that they should not actively seek to identify women with a family history of breast cancer. We have carried out a review of the evidence base and a large scale questionnaire survey of health professionals in four European countries. There is overwhelming support amongst GPs and surgeons against the premise that that health care professionals should not be proactive in identifying patients at risk of familial breast cancer. This that suggest the time is right to overturn the NICE decision.",

keywords = "BRCA1, BRCA2, Breast cancer, Mortality, Proactive, Screening",

author = "H. Harris and I. Nippert and C. Julian-Reynier and J. Schmidtke and \{Van Asperen\}, C. and D. Gadzicki and A. Tibben and Evans, \{D. G.\}",

year = "2011",

month = sep,

day = "1",

doi = "10.1007/s10689-011-9434-1",

language = "English",

volume = "10",

pages = "501--503",

journal = "Familial Cancer ",

issn = "1389-9600",

publisher = "Springer Nature",

number = "3",

}

TY - JOUR

T1 - Familial breast cancer

T2 - Is it time to move from a reactive to a proactive role?

AU - Harris, H.

AU - Nippert, I.

AU - Julian-Reynier, C.

AU - Schmidtke, J.

AU - Van Asperen, C.

AU - Gadzicki, D.

AU - Tibben, A.

AU - Evans, D. G.

PY - 2011/9/1

Y1 - 2011/9/1

N2 - In 2004 the NICE guidelines on familial breast cancer advised Health Care Professionals that they should not actively seek to identify women with a family history of breast cancer. We have carried out a review of the evidence base and a large scale questionnaire survey of health professionals in four European countries. There is overwhelming support amongst GPs and surgeons against the premise that that health care professionals should not be proactive in identifying patients at risk of familial breast cancer. This that suggest the time is right to overturn the NICE decision.

AB - In 2004 the NICE guidelines on familial breast cancer advised Health Care Professionals that they should not actively seek to identify women with a family history of breast cancer. We have carried out a review of the evidence base and a large scale questionnaire survey of health professionals in four European countries. There is overwhelming support amongst GPs and surgeons against the premise that that health care professionals should not be proactive in identifying patients at risk of familial breast cancer. This that suggest the time is right to overturn the NICE decision.

KW - BRCA1

KW - BRCA2

KW - Breast cancer

KW - Mortality

KW - Proactive

KW - Screening

UR - https://www.scopus.com/pages/publications/80055015141

U2 - 10.1007/s10689-011-9434-1

DO - 10.1007/s10689-011-9434-1

M3 - Article

C2 - 21400222

AN - SCOPUS:80055015141

SN - 1389-9600

VL - 10

SP - 501

EP - 503

JO - Familial Cancer

JF - Familial Cancer

IS - 3

ER -

Familial breast cancer: Is it time to move from a reactive to a proactive role?

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this